Sagefield Capital’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,960
Closed -$3.04M 110
2026
Q1
$3.04M Buy
16,960
+10,775
+174% +$1.84M 0.22% 89
2025
Q4
$875K Buy
+6,185
New +$702K 0.07% 98
2024
Q3
Sell
-34,076
Closed -$3.25M 96
2024
Q2
$3.25M Sell
34,076
-10,522
-24% -$1.25M 0.34% 55
2024
Q1
$5.88M Buy
44,598
+17,741
+66% +$2.18M 0.72% 33
2023
Q4
$3.88M Buy
26,857
+2,536
+10% +$348K 0.5% 45
2023
Q3
$4.14M Buy
24,321
+21,781
+858% +$4.34M 0.58% 45
2023
Q2
$567K Buy
+2,540
New +$519K 0.12% 77
2022
Q2
Sell
-1,675
Closed -$371K 143
2022
Q1
$371K Buy
+1,675
New +$354K 0.16% 78

Other funds holding ALB

Sagefield Capital's ALB Position: Q2 2026 in Review

Sagefield Capital sold out of Albemarle (ALB) in Q2 2026, closing a stake of 16,960 shares — an estimated $3.04M sold.

Sagefield Capital first reported a position in ALB in Q1 2022 and held it in 8 quarters. The position peaked at $5.88M in Q1 2024. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Sagefield Capital reported no remaining Albemarle position as of Q2 2026 after selling out during the quarter.
  • Sagefield Capital sold 16,960 Albemarle shares in Q2 2026, an estimated $3.04M.
  • Sagefield Capital first reported a position in Albemarle in Q1 2022 and held it in 8 quarters.
  • Sagefield Capital's Albemarle position peaked at $5.88M in Q1 2024.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Sagefield Capital's 13F filing for Q2 2026, filed 14 Aug 2026.